Market Place
Sourcing Support
Epsilogen Completes £12.5 Million Series B Financing Expansion
09 Sep 2024 //
BUSINESSWIRE
Epsilogen`s MOv18 IgE CTA Approved For Phase Ib In Resistant Ovarian Cancer
08 Jul 2024 //
BUSINESSWIRE
Epsilogen Appoints Ashley Nagle As CBO, Peter Finan As Chairman
01 May 2024 //
BUSINESSWIRE
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18
05 Mar 2024 //
BUSINESSWIRE
Epsilogen Announces Successful Completion of First Ever Trial of an IgE Antibody
25 Jul 2023 //
BUSINESSWIRE
Epsilogen announces significant expansion of management team
26 Apr 2023 //
BUSINESSWIRE
Epsilogen Completes Oversubscribed £30.75M Series B Financing
02 Mar 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.